Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
439.00    71.00 (19.29%)
Bid:
438.00
Ask:
440.00
Spread: 2.00 (0.457%)
Market Cap: £1.20b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Stabilisation Notice

5 Feb 2016 07:00

RNS Number : 1619O
Morgan Stanley & Co. Int'l plc
05 February 2016
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

CMC Markets plc (the "Company")

Stabilisation Notice

5 February 2016

Morgan Stanley & Co. International plc (contact: Martin Thorneycroft: telephone: +44 (0) 20 7425 8000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

CMC Markets plc

Securities:

Ordinary shares of 25 pence each ("Shares") of the Issuer (ISIN: GB00B14SKR37)

Offer size:

90,634,753 Shares ("Offer Shares") (excluding the over-allotment option)

Offer price:

240 pence per Share

Stabilisation:

Stabilising Manager:

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Stabilisation period expected to start on:

5 February 2016 at 8:00 a.m.

Stabilisation period expected to end no later than:

6 March 2016

Maximum size of over-allotment facility:

Up to 13,595,213 Shares

Over-allotment Option:

Terms:

The Selling Shareholders have granted Morgan Stanley & Co. International plc, in its capacity as stabilisation manager, and for the account of the underwriters, the option to acquire up to an additional 13,595,213 Shares at the Offer Price (representing up to 15 per cent of the Offer size).

Duration:

This option may be executed at any time during the stabilisation period.

 

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STATIMJTMBTMTTF
Date   Source Headline
4th Jun 20267:05 amRNSDirectorate change
4th Jun 20267:00 amRNSPreliminary Results
6th May 20264:45 pmRNSDirector/PDMR Shareholding
8th Apr 20263:49 pmRNSDirector/PDMR Shareholding
24th Mar 202610:00 amRNSDirectorate change
6th Mar 20263:54 pmRNSDirector/PDMR Shareholding
6th Feb 20263:57 pmRNSDirector/PDMR Shareholding
12th Jan 202612:16 pmRNSDirector/PDMR Shareholding
6th Jan 20261:38 pmRNSDirector/PDMR Shareholding
8th Dec 20252:22 pmRNSDirector/PDMR Shareholding
20th Nov 20257:10 amRNSDividend Declaration
20th Nov 20257:00 amRNSInterim Results
6th Nov 20254:55 pmRNSDirector/PDMR Shareholding
3rd Nov 20251:30 pmRNSDirectorate change
7th Oct 20254:02 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSWestpac and CMC Extend Strategic Relationship
11th Sep 20259:40 amRNSDirector/PDMR Shareholding
8th Sep 202511:50 amRNSDirector/PDMR Shareholding
5th Sep 202512:14 pmRNSAppointment of Senior Independent Director
19th Aug 20254:22 pmRNSDirector/PDMR Shareholding
19th Aug 20254:20 pmRNSDirector/PDMR Shareholding
7th Aug 20253:59 pmRNSHolding(s) in Company
6th Aug 20254:08 pmRNSDirector/PDMR Shareholding
4th Aug 20251:23 pmRNSDirector/PDMR Shareholding
31st Jul 20253:53 pmRNSDirector/PDMR Shareholding
24th Jul 20251:21 pmRNSResult of AGM
23rd Jul 20255:20 pmRNSDirector/PDMR Shareholding
18th Jul 20252:36 pmRNSDirector/PDMR Shareholding
16th Jul 20254:57 pmRNSDirector/PDMR Shareholding
8th Jul 20253:04 pmRNSDirector/PDMR Shareholding
20th Jun 20255:11 pmRNSNotice of AGM
19th Jun 20254:53 pmRNSDirector/PDMR Shareholding
18th Jun 202512:18 pmRNSDirector/PDMR Shareholding
12th Jun 20259:45 amRNSConfirmation of Dividend Details
6th Jun 20254:07 pmRNSDirector/PDMR Shareholding
5th Jun 202512:48 pmRNSAnnual Financial Report
5th Jun 20257:30 amRNSDividend Declaration
5th Jun 20257:05 amRNSBoard and Directorate Changes
5th Jun 20257:00 amRNSFinal Results
7th May 20253:35 pmRNSDirector/PDMR Shareholding
8th Apr 20252:10 pmRNSDirector/PDMR Shareholding
7th Mar 20254:48 pmRNSDirector/PDMR Shareholding
6th Mar 202512:21 pmRNSDirector/PDMR Shareholding
27th Feb 20253:25 pmRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSDirectorate Change
6th Feb 20253:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
13th Jan 202510:08 amRNSDirector/PDMR Shareholding
6th Jan 20254:24 pmRNSDirector/PDMR Shareholding
6th Dec 202411:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.